Talk:Oncogenic osteomalacia

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Low	This article has been rated as Low-importance on the project's importance scale.
	This article is supported by the Hematology-oncology task force.

Merge Phosphaturic mesenchymal tumor to here?

Done Klbrain (talk) 21:52, 14 May 2017 (UTC)[reply]

I'm too new to add this myself, but could an additional treatment paragraph be added, along the lines of: On June 18, 2020, the U.S. FDA approved a new treatment, Crysvita (burosumab-twza), for tumor-induced osteomalacia. https://www.fda.gov/news-events/press-announcements/fda-approves-first-therapy-rare-disease-causes-low-phosphate-blood-levels-bone-softening

Here's the Wikipedia page for Crysvita/burosumab: https://en.wikipedia.org/wiki/Burosumab AuthorGinJones (talk) 23:12, 19 October 2020 (UTC)[reply]